Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary
Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.
Latest News, Updates & Insights
Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.
Starboard argues Riot’s Texas power assets position the company to secure large AI data center tenants if management accelerates deal execution.
The rise of artificial intelligence is likely to displace millions of workers in quick order, triggering sizable credit defaults, said Hayes.
XRP Ledger has rolled out a “Permissioned DEX” upgrade allowing regulated institutions to operate gated, members-only onchain trading venues.
Jake Chervinsky, CEO of the Hyperliquid Policy Center, said markets are migrating to blockchain, and the U.S. need to adopt new rules of risk being left behind.
Ultan Miller touts a blockchain-based pre-IPO index, while critics warn unauthorized equity tokenization risks legal and investor fallout.
The Nasdaq-listed SUIS fund offers direct exposure to Sui’s native token while passing through proof-of-stake rewards in a regulated ETF wrapper.
The independent research and advocacy organization will be dedicated to ensuring that DeFi can flourish in the U.S., according to Hyperliquid.
Two spot SUI exchange-traded funds hit the market on Wednesday, offering investors direct exposure to the token's price.
Solana (SOL), down 2.5% from Tuesday, was also among the underperformers.
Crypto's next major use case has arrived: powering autonomous AI agents. And they're already using "natural selection" to evolve onchain...
Brevan Howard’s BH Digital Asset fund fell 29.5% in 2025, its worst performance since the crypto-focused fund's 2021 launch.